Stephanie Davis
Stock Analyst at Barclays
(0)
# 4477
Out of 5,329 analysts
163
Total ratings
37.14%
Success rate
-15.20%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
DGX Quest Diagnostics | Maintains: Equal-Weight | 175 185 | 178.21 | 3.81% | 5 | Apr 23, 2025 | |
WAY Waystar Holding | Maintains: Overweight | 50 45 | 40.03 | 12.42% | 3 | Apr 14, 2025 | |
OPRX OptimizeRx | Maintains: Equal-Weight | 11 5 | 9.82 | -49.08% | 3 | Nov 14, 2024 | |
DOCS Doximity | Maintains: Overweight | 52 75 | 59.91 | 25.19% | 5 | Nov 11, 2024 | |
LFST LifeStance Health Gr | Maintains: Underweight | 6 7 | 6.64 | 5.42% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 10 6 | 4.78 | 25.52% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 39 19 | 10.21 | 86.09% | 1 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 263 290 | 293 | -1.02% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 20 24 | 20.58 | 16.62% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 117 133 | 148.06 | -10.17% | 2 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 39 58 | 31.93 | 81.65% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 3 | 3.13 | -4.15% | 7 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 1 1 | 0.63 | 19.05% | 3 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 6 5 | n/a | n/a | 10 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 213 249 | 244.74 | 1.74% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 14 14 | n/a | n/a | 6 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 12 10 | n/a | n/a | 6 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 29 | 25.78 | 12.49% | 11 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 11 | n/a | n/a | 10 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 34 | 7.02 | 384.33% | 9 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 59 34 | 23.06 | 47.44% | 3 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 242 233 | 237.79 | -2.01% | 9 | Dec 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 17 | 4.08 | 316.67% | 10 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 25 | n/a | n/a | 6 | Oct 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 67 76 | 90.01 | -15.56% | 5 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 11 4 | n/a | n/a | 7 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 88 95 | n/a | n/a | 4 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 34 36 | n/a | n/a | 4 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 45 41 | 31.08 | 31.92% | 4 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 56 | n/a | n/a | 7 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 55 53 | n/a | n/a | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 35 | n/a | n/a | 2 | Aug 10, 2020 |